Annotation Detail
Information
- Associated Genes
- ESR1
- Associated Variants
-
FGFR2 c.109+906T>C
(
ENST00000683211.1,
ENST00000357555.9,
ENST00000683035.1,
ENST00000346997.6,
ENST00000369061.8,
ENST00000457416.7,
ENST00000356226.8,
ENST00000684153.1,
ENST00000611527.1,
ENST00000682550.1,
ENST00000613048.4,
ENST00000359354.6,
ENST00000369056.5,
ENST00000360144.7,
ENST00000369059.5,
ENST00000351936.11,
ENST00000369060.8,
ENST00000358487.10 )
rs3803662
FGFR2 c.109+906T>C ( ENST00000683211.1, ENST00000684153.1, ENST00000346997.6, ENST00000351936.11, ENST00000356226.8, ENST00000357555.9, ENST00000358487.10, ENST00000359354.6, ENST00000360144.7, ENST00000369056.5, ENST00000369059.5, ENST00000369060.8, ENST00000369061.8, ENST00000457416.7, ENST00000611527.1, ENST00000613048.4, ENST00000682550.1, ENST00000683035.1 )
rs3803662 - Associated Disease
- Malignant neoplasm of breast
- Source Database
- DisGeNET
- Description
- We also confirmed that SNPs in FGFR2 and TNRC9 were associated with greater risk of estrogen receptor-positive than estrogen receptor-negative breast cancer (P(heterogeneity) = .0016 for FGFR2-rs2981582 and P(heterogeneity) = .0053 for TNRC9-rs3803662).
- Pubmed
- 21791674
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.24
- Year of publication
- 2011
Drugs